CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Thermo Fisher Scientific - TMO CFD

564.30
0.93%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.56
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Thermo Fisher Scientific Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 560.03
Open* 562.36
1-Year Change* 2.57%
Day's Range* 562.36 - 565.67
52 wk Range 415.60-609.85
Average Volume (10 days) 2.02M
Average Volume (3 months) 40.15M
Market Cap 210.35B
P/E Ratio 35.65
Shares Outstanding 386.37M
Revenue 43.42B
EPS 15.27
Dividend (Yield %) 0.25715
Beta 0.80
Next Earnings Date Jan 31, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 564.30 3.34 0.60% 560.96 566.49 559.39
Feb 22, 2024 560.03 9.47 1.72% 550.56 560.47 548.68
Feb 21, 2024 552.57 7.67 1.41% 544.90 552.80 543.47
Feb 20, 2024 548.02 5.95 1.10% 542.07 550.07 542.06
Feb 16, 2024 546.23 1.91 0.35% 544.32 552.34 544.32
Feb 15, 2024 548.60 2.70 0.49% 545.90 552.68 543.94
Feb 14, 2024 546.81 9.72 1.81% 537.09 548.59 537.09
Feb 13, 2024 538.48 -2.88 -0.53% 541.36 545.19 533.65
Feb 12, 2024 546.46 -1.88 -0.34% 548.34 549.00 543.49
Feb 9, 2024 550.58 2.40 0.44% 548.18 553.61 545.94
Feb 8, 2024 550.85 0.51 0.09% 550.34 550.96 541.35
Feb 7, 2024 550.96 -9.94 -1.77% 560.90 565.16 550.96
Feb 6, 2024 560.09 8.52 1.54% 551.57 560.23 550.41
Feb 5, 2024 551.35 6.89 1.27% 544.46 556.38 544.44
Feb 2, 2024 551.68 4.80 0.88% 546.88 554.34 541.38
Feb 1, 2024 552.06 12.17 2.25% 539.89 553.63 532.68
Jan 31, 2024 536.50 -24.56 -4.38% 561.06 565.43 536.34
Jan 30, 2024 566.83 6.95 1.24% 559.88 569.61 557.55
Jan 29, 2024 557.17 9.26 1.69% 547.91 559.03 544.78
Jan 26, 2024 547.08 -5.48 -0.99% 552.56 555.65 545.96

Thermo Fisher Scientific Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Thermo Fisher Scientific Inc Earnings Release
Q1 2024 Thermo Fisher Scientific Inc Earnings Release

Forecast

-

Previous

-
Thursday, May 23, 2024

Time (UTC)

17:00

Country

US

Event

Thermo Fisher Scientific Inc Annual Shareholders Meeting
Thermo Fisher Scientific Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 44915 39211 32218 25542 24358
Revenue 44915 39211 32218 25542 24358
Cost of Revenue, Total 25944 19573 16231 14213 13499
Gross Profit 18971 19638 15987 11329 10859
Total Operating Expense 36548 29950 24424 21132 20575
Selling/General/Admin. Expenses, Total 8934 7816 6940 6082 6028
Research & Development 1471 1406 1181 1003 967
Unusual Expense (Income) 140 1108 89 -167 79
Operating Income 8367 9261 7794 4410 3783
Interest Income (Expense), Net Non-Operating -548 -427 -569 -408 -528
Other, Net 16 7 68 7
Net Income Before Taxes 7835 8841 7225 4070 3262
Net Income After Taxes 7132 7732 6375 3704 3055
Net Income Before Extra. Items 6950 7725 6375 3704 3055
Total Extraordinary Items 0 -8 -117
Net Income 6950 7725 6375 3696 2938
Income Available to Common Excl. Extra. Items 6950 7725 6375 3704 3055
Income Available to Common Incl. Extra. Items 6950 7725 6375 3696 2938
Diluted Net Income 6950 7725 6375 3696 2938
Diluted Weighted Average Shares 394 397 399 403 406
Diluted EPS Excluding Extraordinary Items 17.6396 19.4584 15.9774 9.19107 7.52463
Dividends per Share - Common Stock Primary Issue 1.16 1 0.85 0.74 0.66
Diluted Normalized EPS 18.0254 21.9169 16.1875 8.85233 7.73455
Interest Expense (Income) - Net Operating -17 1 2
Other Operating Expenses, Total 59 47
Minority Interest -10 -3
Equity In Affiliates -172 -4
Sep 2023 Jul 2023 Apr 2023 Dec 2022 Oct 2022
Total revenue 10574 10687 10710 11450 10677
Revenue 10574 10687 10710 11450 10677
Cost of Revenue, Total 6145 6436 6570 6844 6375
Gross Profit 4429 4251 4140 4606 4302
Total Operating Expense 8710 9109 9147 9589 8967
Selling/General/Admin. Expenses, Total 1578 2145 2119 2240 2208
Research & Development 319 345 346 391 351
Unusual Expense (Income) 84 183 112 55 33
Operating Income 1864 1578 1563 1861 1710
Interest Income (Expense), Net Non-Operating -113 -148 -198 -144 -118
Other, Net 14 0 -2 60 9
Net Income Before Taxes 1765 1430 1363 1777 1601
Net Income After Taxes 1712 1378 1317 1604 1570
Net Income Before Extra. Items 1715 1361 1289 1576 1495
Net Income 1715 1361 1289 1576 1495
Income Available to Common Excl. Extra. Items 1715 1361 1289 1576 1495
Income Available to Common Incl. Extra. Items 1715 1361 1289 1576 1495
Diluted Net Income 1715 1361 1289 1576 1495
Diluted Weighted Average Shares 388 388 388 392 395
Diluted EPS Excluding Extraordinary Items 4.4201 3.50773 3.32216 4.02041 3.78481
Dividends per Share - Common Stock Primary Issue 0.35 0.35 0.3 0.3 0.3
Diluted Normalized EPS 4.6176 3.9672 3.67828 4.15857 3.92135
Other Operating Expenses, Total 59
Minority Interest 20 -1 -3 2 -3
Equity In Affiliates -17 -16 -25 -30 -72
Depreciation / Amortization 584
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 25229 20113 21957 11893 10625
Cash and Short Term Investments 8526 4477 10353 2436 2134
Cash & Equivalents 8524 4477 10325 2399 2103
Short Term Investments 2 28 37 31
Total Receivables, Net 9427 8945 6472 4952 4136
Accounts Receivable - Trade, Net 9427 8945 6472 4952 4136
Total Inventory 5634 5051 4029 3370 3005
Other Current Assets, Total 1642 1640 1103 1135 1350
Total Assets 97154 95123 69052 58381 56232
Property/Plant/Equipment, Total - Net 10873 9864 6687 5448 4165
Property/Plant/Equipment, Total - Gross 15862 14124 10352 8463 6820
Accumulated Depreciation, Total -4989 -4260 -3665 -3015 -2655
Goodwill, Net 41196 41924 26041 25714 25347
Intangibles, Net 17442 20113 12685 14014 14978
Other Long Term Assets, Total 2352 3087 1682 1312 1117
Total Current Liabilities 17010 13436 10304 6197 6147
Accounts Payable 3381 2867 2175 1920 1615
Accrued Expenses 5433 5377 4098 2674 2436
Notes Payable/Short Term Debt 310 2522 0 0 0
Current Port. of LT Debt/Capital Leases 5269 15 2628 676 1271
Other Current Liabilities, Total 2617 2655 1403 927 825
Total Liabilities 53176 54330 34545 28706 28646
Total Long Term Debt 28909 32333 19107 17076 17719
Long Term Debt 28909 32333 19107 17076 17719
Deferred Income Tax 2849 3837 1794 2192 2265
Other Liabilities, Total 4238 4540 3340 3241 2515
Total Equity 43978 40793 34507 29675 27586
Common Stock 441 439 437 434 432
Additional Paid-In Capital 16743 16174 15579 15064 14621
Retained Earnings (Accumulated Deficit) 41910 35431 28116 22092 18696
Treasury Stock - Common -12017 -8922 -6818 -5236 -3665
Unrealized Gain (Loss) -33 -35 -91 -71 -52
Other Equity, Total -3066 -2294 -2716 -2608 -2446
Total Liabilities & Shareholders’ Equity 97154 95123 69052 58381 56232
Total Common Shares Outstanding 390.511 394.435 396.671 398.74 402.122
Long Term Investments 55 22
Minority Interest 170 184
Note Receivable - Long Term 7
Sep 2023 Jul 2023 Apr 2023 Dec 2022 Oct 2022
Total Current Assets 23092 19995 20209 25229 19299
Cash and Short Term Investments 6151 3133 3482 8526 2941
Cash & Equivalents 6151 3133 3482 8524 2919
Short Term Investments 2 22
Total Receivables, Net 9835 9486 9297 9427 8919
Accounts Receivable - Trade, Net 9835 9486 9297 9427 8919
Total Inventory 5404 5655 5664 5634 5722
Other Current Assets, Total 1702 1721 1766 1642 1717
Total Assets 97057 94105 94658 97154 90536
Property/Plant/Equipment, Total - Net 9167 9292 9354 9280 8628
Goodwill, Net 43583 43273 43140 41196 40488
Intangibles, Net 17091 17437 17972 17442 17813
Other Long Term Assets, Total 4119 4102 3975 4000 4299
Total Current Liabilities 14158 14112 15884 17010 11118
Accounts Payable 2508 2423 2798 3381 2471
Accrued Expenses 4308 4285 4302 5433 5068
Notes Payable/Short Term Debt 0 500 824 310 0
Current Port. of LT Debt/Capital Leases 4795 4314 5298 5269 1010
Other Current Liabilities, Total 2547 2590 2662 2617 2569
Total Liabilities 51729 50353 52401 53176 46987
Total Long Term Debt 30489 29194 29135 28909 28150
Long Term Debt 30489 29194 29135 28909 28150
Deferred Income Tax 2620 2842 2976 2849 3140
Other Liabilities, Total 4326 4042 4230 4238 4401
Total Equity 45328 43752 42257 43978 43549
Common Stock 442 441 441 441 440
Additional Paid-In Capital 17165 17030 16889 16743 16596
Retained Earnings (Accumulated Deficit) 45869 44289 43064 41910 40452
Treasury Stock - Common -15121 -15084 -15083 -12017 -11011
Unrealized Gain (Loss) -28 -29 -30 -33 -33
Other Equity, Total -2999 -2895 -3024 -3066 -2895
Total Liabilities & Shareholders’ Equity 97057 94105 94658 97154 90536
Total Common Shares Outstanding 386.372 385.95 385.721 390.511 392.196
Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Minority Interest 136 163 176 170 178
Note Receivable - Long Term 5 6 8 7 9
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 6960 7728 6375 3696 2938
Cash From Operating Activities 9154 9312 8289 4973 4543
Cash From Operating Activities 986 831 658 564 2267
Deferred Taxes -995 -647 -552 -302 -379
Non-Cash Items 857 1187 536 -33 287
Changes in Working Capital -1049 -1548 -395 -665 -570
Cash From Investing Activities -2159 -21932 -1510 -1487 -1253
Capital Expenditures -2243 -2523 -1474 -926 -758
Other Investing Cash Flow Items, Total 84 -19409 -36 -561 -495
Cash From Financing Activities -2810 6581 959 -3118 -2237
Financing Cash Flow Items -9 -91 -147 -69 -51
Total Cash Dividends Paid -455 -395 -337 -297 -266
Issuance (Retirement) of Stock, Net -3000 -1844 -1304 -1347 -364
Issuance (Retirement) of Debt, Net 654 8911 2747 -1405 -1556
Foreign Exchange Effects -139 194 176 -63 -297
Net Change in Cash 4046 -5845 7914 305 756
Cash Taxes Paid 1234 2182 1324 896 591
Cash Interest Paid 667 555 471 790 687
Amortization 2395 1761 1667 1713
Apr 2023 Dec 2022 Oct 2022 Jul 2022 Apr 2022
Net income/Starting Line 1292 6960 5386 3888 2220
Cash From Operating Activities 729 9154 5667 3730 2202
Cash From Operating Activities 253 986 730 486 250
Amortization 606 2395 1803 1209 609
Deferred Taxes -146 -995 -862 -601 -339
Non-Cash Items 257 857 701 472 337
Changes in Working Capital -1533 -1049 -2091 -1724 -875
Cash From Investing Activities -3142 -2159 -1634 -1089 -670
Capital Expenditures -458 -2243 -1693 -1146 -640
Other Investing Cash Flow Items, Total -2684 84 59 57 -30
Cash From Financing Activities -2593 -2810 -5201 -5050 -3145
Financing Cash Flow Items 20 -9 -86 -48 -36
Total Cash Dividends Paid -117 -455 -338 -220 -103
Issuance (Retirement) of Stock, Net -3000 -3000 -1943 -1949 -1998
Issuance (Retirement) of Debt, Net 504 654 -2834 -2833 -1008
Foreign Exchange Effects -31 -139 -389 -177 -99
Net Change in Cash -5037 4046 -1557 -2586 -1712
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.3978 32411301 3067 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.7696 18408301 -388612 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.1759 16116956 55458 2023-06-30 LOW
Capital World Investors Investment Advisor 3.3362 12876098 -48366 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.2469 8672091 -2077992 2023-06-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.2212 8572754 547312 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8082 6978869 -6715 2023-06-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 1.6887 6517361 -1270699 2023-06-30 LOW
Capital Research Global Investors Investment Advisor 1.5783 6091325 157512 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4612 5639611 219567 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 1.1087 4278887 209573 2023-06-30 LOW
Morgan Stanley Investment Management Ltd. (UK) Investment Advisor 1.0313 3980403 378915 2023-06-30 LOW
TCI Fund Management Limited Hedge Fund 0.8222 3173182 2339032 2023-06-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.8035 3100948 -193634 2023-06-30 LOW
PRIMECAP Management Company Investment Advisor 0.7975 3078107 -486002 2023-06-30
JP Morgan Asset Management Investment Advisor 0.7742 2987984 -243076 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.7271 2806223 -83893 2023-06-30 LOW
BofA Global Research (US) Research Firm 0.7041 2717630 -367618 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6763 2610108 50802 2023-06-30 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 0.6678 2577185 -145338 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Thermo Fisher Company profile

Thermo Fisher Scientific Inc. (TMO) is a supplier of scientific laboratory products, instruments, software and other tools. The company was formed in a tax-free stock-for-stock merger of Thermo Electron Corporation with Fisher Scientific International Inc. in 2006. 

The company provides services through various brands including Thermo Fishers, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. 

Thermo Fisher works on accelerating life sciences research by solving complex analytical challenges. Its products aim to increase productivity in laboratories and improve patient health through diagnostics and therapy development. 

The four segments that Thermo Fisher Scientific caters to are industrial and applied research, diagnostics and healthcare, academic and government research, and pharmaceuticals and biotechnology. 

As of June 2022, Thermo Fisher has developed Orbitrap Exploris MX mass spectrometer, cell therapy workflow solutions, Oncomine Dx Target Test and several other solutions that aim to make the diagnosis of infections and diseases easier and enable production of drugs and vaccines. 

Thermo Fisher Scientific Inc. stock is trading on the New York Stock Exchange (NYSE) under the ticker symbol TMO. You can follow live TMO stock movement and price history, and stay on top of the latest TMO share value at Capital.com.

Industry: Advanced Medical Equipment & Technology (NEC)

168 Third Avenue
WALTHAM
MASSACHUSETTS 02451
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

17,914.30 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

51,616.75 Price
+1.190% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Oil - Crude

76.56 Price
-2.240% 1D Chg, %
Long position overnight fee 0.0163%
Short position overnight fee -0.0382%
Overnight fee time 22:00 (UTC)
Spread 0.030

Gold

2,035.76 Price
+0.560% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading